Trial Profile
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA, Versus Standard Dose Tacrolimus, ECMPA Plus Corticosteroids in Patients Undergoing Liver Transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2022
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary) ; Hydrocortisone; Mycophenolate; Tacrolimus
- Indications Kidney disorders
- Focus Therapeutic Use
- 13 Jul 2022 Status changed from recruiting to completed.
- 10 Jul 2014 New trial record